FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2931876969> ?p ?o ?g. }

• W2931876969 endingPage "166" @default.
• W2931876969 startingPage "157" @default.
• W2931876969 abstract "3, 4-Methylenedioxymethamphetamine (MDMA) is a hallucinogenic amphetamine derivative. The acute effects of MDMA are hyperthermia, hyperactivity, and behavioral changes, followed by long-term serotonergic neurotoxicity in rats and primates. However, the underlying mechanisms of MDMA neurotoxicity remain elusive. We reported that pretreatment of rats with Ro 4-1284, a reversible inhibitor of the vesicular monoamine transporter 2 (VMAT2), reduced MDMA-induced hyperactivity in rats, abolished the hyperthermic response, and the long-term neurotoxicity. Current studies focused on the effects of co- and/or postinhibition of VMAT2 on the acute and chronic effects of MDMA and on the dose-response relationship between MDMA-induced elevations in body temperature and subsequent reductions in indolamine concentrations. Sprague Dawley rats were treated with MDMA (20, 25, or 27.5 mg/kg sc), and either co- and/or posttreatment with the VMAT2 inhibitor (10 mg/kg ip). Rats simultaneously treated with Ro 4-1284 and MDMA exhibited a more rapid increase in body temperature compared to just MDMA. However, the duration of the elevated body temperature was significantly shortened (approximately 3 h vs approximately 8 h, respectively). A similar body temperature response was observed in rats posttreated (7 h after MDMA) with Ro 4-1284. Despite decreases in the area under the curve (Δtemp X time) of body temperature caused by Ro 4-1284, there were no significant differences in the degree of indolamine depletion between any of the MDMA-treated groups. The results suggest that the neuroprotective effects of VMAT2 inhibition is likely due to the indirect monoamine depleting effects of the Ro 4-1284 pretreatment, rather than by the direct inhibition of VMAT2 function." @default.
• W2931876969 created "2019-04-11" @default.
• W2931876969 creator A5060909286 @default.
• W2931876969 creator A5060996003 @default.
• W2931876969 creator A5086522629 @default.
• W2931876969 creator A5091188351 @default.
• W2931876969 date "2019-03-28" @default.
• W2931876969 modified "2023-09-27" @default.
• W2931876969 title "Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity" @default.
• W2931876969 cites W1562529961 @default.
• W2931876969 cites W1574496069 @default.
• W2931876969 cites W1894300836 @default.
• W2931876969 cites W1949070403 @default.
• W2931876969 cites W1966305781 @default.
• W2931876969 cites W1968332094 @default.
• W2931876969 cites W1969779696 @default.
• W2931876969 cites W1971746914 @default.
• W2931876969 cites W1983592473 @default.
• W2931876969 cites W1984280476 @default.
• W2931876969 cites W1990508321 @default.
• W2931876969 cites W1990635104 @default.
• W2931876969 cites W1991141166 @default.
• W2931876969 cites W1991809846 @default.
• W2931876969 cites W1994094794 @default.
• W2931876969 cites W1994731568 @default.
• W2931876969 cites W2000293969 @default.
• W2931876969 cites W2001929248 @default.
• W2931876969 cites W2008973569 @default.
• W2931876969 cites W2009328760 @default.
• W2931876969 cites W2012381088 @default.
• W2931876969 cites W2015068634 @default.
• W2931876969 cites W2021041549 @default.
• W2931876969 cites W2026052268 @default.
• W2931876969 cites W2035055624 @default.
• W2931876969 cites W2043018270 @default.
• W2931876969 cites W2044674210 @default.
• W2931876969 cites W2048841731 @default.
• W2931876969 cites W2057484845 @default.
• W2931876969 cites W2058876115 @default.
• W2931876969 cites W2060772857 @default.
• W2931876969 cites W2071776725 @default.
• W2931876969 cites W2073494415 @default.
• W2931876969 cites W2081716945 @default.
• W2931876969 cites W2082609266 @default.
• W2931876969 cites W2095264818 @default.
• W2931876969 cites W2100507133 @default.
• W2931876969 cites W2105243029 @default.
• W2931876969 cites W2105625596 @default.
• W2931876969 cites W2109698385 @default.
• W2931876969 cites W2113363590 @default.
• W2931876969 cites W2115290225 @default.
• W2931876969 cites W2118438870 @default.
• W2931876969 cites W2118964451 @default.
• W2931876969 cites W2128951033 @default.
• W2931876969 cites W2133439321 @default.
• W2931876969 cites W2143308851 @default.
• W2931876969 cites W2145946906 @default.
• W2931876969 cites W2148562084 @default.
• W2931876969 cites W2161294654 @default.
• W2931876969 cites W2194633751 @default.
• W2931876969 cites W2198168203 @default.
• W2931876969 cites W2275207943 @default.
• W2931876969 cites W2430632207 @default.
• W2931876969 doi "https://doi.org/10.1093/toxsci/kfz085" @default.
• W2931876969 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6592187" @default.
• W2931876969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30923810" @default.
• W2931876969 hasPublicationYear "2019" @default.
• W2931876969 type Work @default.
• W2931876969 sameAs 2931876969 @default.
• W2931876969 citedByCount "1" @default.
• W2931876969 countsByYear W29318769692023 @default.
• W2931876969 crossrefType "journal-article" @default.
• W2931876969 hasAuthorship W2931876969A5060909286 @default.
• W2931876969 hasAuthorship W2931876969A5060996003 @default.
• W2931876969 hasAuthorship W2931876969A5086522629 @default.
• W2931876969 hasAuthorship W2931876969A5091188351 @default.
• W2931876969 hasBestOaLocation W29318769692 @default.
• W2931876969 hasConcept C118552586 @default.
• W2931876969 hasConcept C126322002 @default.
• W2931876969 hasConcept C134018914 @default.
• W2931876969 hasConcept C170493617 @default.
• W2931876969 hasConcept C178790620 @default.
• W2931876969 hasConcept C185592680 @default.
• W2931876969 hasConcept C187714386 @default.
• W2931876969 hasConcept C2775864247 @default.
• W2931876969 hasConcept C2777193897 @default.
• W2931876969 hasConcept C2778406628 @default.
• W2931876969 hasConcept C2779488553 @default.
• W2931876969 hasConcept C2779491297 @default.
• W2931876969 hasConcept C2779949491 @default.
• W2931876969 hasConcept C2780876324 @default.
• W2931876969 hasConcept C29730261 @default.
• W2931876969 hasConcept C37000724 @default.
• W2931876969 hasConcept C513476851 @default.
• W2931876969 hasConcept C55493867 @default.
• W2931876969 hasConcept C71924100 @default.
• W2931876969 hasConcept C98274493 @default.
• W2931876969 hasConceptScore W2931876969C118552586 @default.

• next